# enGene Therapeutics Inc.: Form DEF 14A, filed May 9, 2025

- Company: [enGene Therapeutics Inc.](/companies/engn.md) (CIK 1980845)
- Form: DEF 14A
- Filed: 2025-05-09
- Accepted by EDGAR: May 9, 2025, 16:05 ET
- Period: 2025-06-10
- Accession: 0001140361-25-018155
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1980845/000114036125018155/ef20048337_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1980845/000114036125018155/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1980845/000114036125018155/ef20048337_def14a.htm

Filed May 9, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-018155. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.